Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

DAC: The Data Analytics Centre of the Danish Medicines Agency

Read about DAC, the Data Analytics Centre of the Danish Medicines Agency. DAC will work to transform information and data on medicine and medicine devices into knowledge that can benefit the citizens.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2


Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.


Data requirements in place in the EU for second-generation COVID-19 vaccines

26 February 2021

With continued mutations of SARS-CoV-2, the current COVID-19 vaccines may need to be adapted to ensure their efficacy. To ensure that second-generation vaccines can be made available as fast as possible, the European Medicines Agency has just issued guidance for manufacturers.

Danish Medicines Agency expands capacity for safety monitoring of COVID-19 vaccines

10 February 2021

Home-based clinical trials will be possible in the future

20 January 2021

EMA’s expert committee meets 6 January to decide on Moderna’s COVID-19 vaccine

22 December 2020